Nexo Therapeutics
Chris Yoo is a Research Scientist at Nexo Therapeutics with experience in optimizing and performing various assays to identify candidate molecules. With a Master's degree in Life Sciences from Virginia Tech, Chris has a strong background in biochemistry and research. Prior to Nexo Therapeutics, Chris worked as a Senior Research Associate at Cyteir Therapeutics, where Chris collaborated with ELN software developers and trained new research associates. Alongside their professional career, Chris has also served in the United States Marine Corps as a Fire Direction Center Chief & Vehicle Commander, showcasing leadership and organizational skills.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.